Literature DB >> 19295147

Reverse signaling by glycosylphosphatidylinositol-linked Manduca ephrin requires a SRC family kinase to restrict neuronal migration in vivo.

Thomas M Coate1, Tracy L Swanson, Philip F Copenhaver.   

Abstract

Reverse signaling via glycosylphosphatidylinositol (GPI)-linked Ephrins may help control cell proliferation and outgrowth within the nervous system, but the mechanisms underlying this process remain poorly understood. In the embryonic enteric nervous system (ENS) of the moth Manduca sexta, migratory neurons forming the enteric plexus (EP cells) express a single Ephrin ligand (GPI-linked MsEphrin), whereas adjacent midline cells that are inhibitory to migration express the cognate receptor (MsEph). Knocking down MsEph receptor expression in cultured embryos with antisense morpholino oligonucleotides allowed the EP cells to cross the midline inappropriately, consistent with the model that reverse signaling via MsEphrin mediates a repulsive response in the ENS. Src family kinases have been implicated in reverse signaling by type-A Ephrins in other contexts, and MsEphrin colocalizes with activated forms of endogenous Src in the leading processes of the EP cells. Pharmacological inhibition of Src within the developing ENS induced aberrant midline crossovers, similar to the effect of blocking MsEphrin reverse signaling. Hyperstimulating MsEphrin reverse signaling with MsEph-Fc fusion proteins induced the rapid activation of endogenous Src specifically within the EP cells, as assayed by Western blots of single embryonic gut explants and by whole-mount immunostaining of cultured embryos. In longer cultures, treatment with MsEph-Fc caused a global inhibition of EP cell migration and outgrowth, an effect that was prevented by inhibiting Src activation. These results support the model that MsEphrin reverse signaling induces the Src-dependent retraction of EP cell processes away from the enteric midline, thereby helping to confine the neurons to their appropriate pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295147      PMCID: PMC3100805          DOI: 10.1523/JNEUROSCI.5464-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

Review 1.  Multiple roles of EPH receptors and ephrins in neural development.

Authors:  D G Wilkinson
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

2.  Eph-ephrin promiscuity is now crystal clear.

Authors:  Elena B Pasquale
Journal:  Nat Neurosci       Date:  2004-05       Impact factor: 24.884

3.  Focal adhesion kinase (FAK) expression and phosphorylation in sea urchin embryos.

Authors:  María Guadalupe García; Sarah Johnson Toney; Merrill B Hille
Journal:  Gene Expr Patterns       Date:  2004-03       Impact factor: 1.224

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

5.  An ephrin-A-dependent signaling pathway controls integrin function and is linked to the tyrosine phosphorylation of a 120-kDa protein.

Authors:  J Huai; U Drescher
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

6.  The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.

Authors:  K Ogawa; R Pasqualini; R A Lindberg; R Kain; A L Freeman; E B Pasquale
Journal:  Oncogene       Date:  2000-12-07       Impact factor: 9.867

7.  Microtubule dynamics are necessary for SRC family kinase-dependent growth cone steering.

Authors:  Daniel M Suter; Andrew W Schaefer; Paul Forscher
Journal:  Curr Biol       Date:  2004-07-13       Impact factor: 10.834

8.  Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.

Authors:  Juha-Pekka Himanen; Michael J Chumley; Martin Lackmann; Chen Li; William A Barton; Phillip D Jeffrey; Christopher Vearing; Detlef Geleick; David A Feldheim; Andrew W Boyd; Mark Henkemeyer; Dimitar B Nikolov
Journal:  Nat Neurosci       Date:  2004-04-25       Impact factor: 24.884

9.  Ephrin-B1 forward and reverse signaling are required during mouse development.

Authors:  Alice Davy; Josée Aubin; Philippe Soriano
Journal:  Genes Dev       Date:  2004-03-01       Impact factor: 11.361

10.  A role for the EphA family in the topographic targeting of vomeronasal axons.

Authors:  B Knöll; K Zarbalis; W Wurst; U Drescher
Journal:  Development       Date:  2001-03       Impact factor: 6.868

View more
  6 in total

Review 1.  Signaling from axon guidance receptors.

Authors:  Greg J Bashaw; Rüdiger Klein
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-24       Impact factor: 10.005

2.  Otic mesenchyme cells regulate spiral ganglion axon fasciculation through a Pou3f4/EphA4 signaling pathway.

Authors:  Thomas M Coate; Steven Raft; Xiumei Zhao; Aimee K Ryan; E Bryan Crenshaw; Matthew W Kelley
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

3.  Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration.

Authors:  Jenna M Ramaker; Tracy L Swanson; Philip F Copenhaver
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

4.  Ephrin-B2/EphA4 forward signaling is required for regulation of radial migration of cortical neurons in the mouse.

Authors:  Yan Hu; Sen Li; Hua Jiang; Ming-Tao Li; Jia-Wei Zhou
Journal:  Neurosci Bull       Date:  2014-01-29       Impact factor: 5.203

5.  A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug.

Authors:  Philip F Copenhaver; Thimmappa S Anekonda; Derek Musashe; Kristine M Robinson; Jenna M Ramaker; Tracy L Swanson; Teri L Wadsworth; Doris Kretzschmar; Randall L Woltjer; Joseph F Quinn
Journal:  Dis Model Mech       Date:  2011-05-19       Impact factor: 5.758

6.  Amyloid Precursor Proteins Are Dynamically Trafficked and Processed during Neuronal Development.

Authors:  Jenna M Ramaker; Robert S Cargill; Tracy L Swanson; Hanil Quirindongo; Marlène Cassar; Doris Kretzschmar; Philip F Copenhaver
Journal:  Front Mol Neurosci       Date:  2016-11-25       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.